Long-term Treatment With Ponesimod in Relapsing-Remitting Multiple Sclerosis: Results From Randomized Phase 2b Core and Extension Studies.

Mark S FreedmanCarlo PozzilliEva Kubala HavrdovaAlexandre LemleMichel BurcklenAnna LarbalestierBrian HennessyTatiana SidorenkoAndrea VaclavkovaTomas Olssonnull null

Published in: Neurology (2022)

EudraCT Number 2008-006786-92 (Core study) and EudraCT Number 2009-011470-15 (Extension study).

Keyphrases

multiple sclerosis
randomized controlled trial
white matter
disease activity
rheumatoid arthritis
systemic lupus erythematosus
phase iii
combination therapy